US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn
Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)
Rebecca Stevenson
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

More Markets

Eroad shares slump 23% as it shifts focus from North America
Markets

Eroad shares slump 23% as it shifts focus from North America

Eroad cuts North America exposure, impairing $150m in assets.

$55m deal secures Santana mining land
Primary Sector

$55m deal secures Santana mining land

The gold miner now owns all the land where its best mining prospects lie.  

Open banking's red tape may stifle lenders' innovation: fintechs
Policy

Open banking's red tape may stifle lenders' innovation: fintechs

Fee-free open banking and levies may deter banks from innovating with new tech.

Spot market power prices 'past their peak': Genesis
Markets

Spot market power prices 'past their peak': Genesis

Genesis has 1.1 million tonnes of coal stockpiled for use at the Huntly Power Station.